Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Randomised, Parallel-group, Multicentre, Observational Trial to Evaluate Safety and Efficacy of Edoxaban Tosylate in Children From 38 Weeks Gestational Age to Less Than 18 Years of Age With Cardiac Diseases at Risk of Thromboembolic Events

NCT03395639 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT03395639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03395639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Randomised, Parallel-group, Multicentre, Observational Trial to Evaluate Safety and Efficacy of Edoxaban Tosylate in Children From 38 Weeks Gestational Age to Less Than 18 Years of Age With Cardiac Diseases at Risk of Thromboembolic Events
Lead sponsor
Daiichi Sankyo
Phase
Phase 3
Overall status
Completed
Start date
May 15, 2018
Completion date
December 3, 2021
Enrollment
168 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac disease